FDA Clearance Tracker · P100026-S047
NeuroPace RNS System
Last checked: Nov 20, 2026Latest source record: Aug 14, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Aug 14, 2017
Approved
Time to decision
180 days
Received Feb 15, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100026-S047
- Device name
- NeuroPace RNS System
- Applicant
- NeuroPace, Inc.
- Applicant location
- Mountain View, CA
- Received
- Feb 15, 2017
- Decided
- Aug 14, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100026
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Neurostimulator (model RNS-320), NeuroPace Programmer (model 5000), Patient Data Management System (PDMS, model 4340), and Remote Monitor (model 5100).
Source documents
Other decisions for NeuroPace, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.